Xylem (NYSE:XYL) Hits New 1-Year High After Analyst Upgrade

Xylem Inc. (NYSE:XYL) reached a new 52-week high on Monday after Royal Bank of Canada raised their price target on the stock from $157.00 to $162.00. Royal Bank of Canada currently has an outperform rating on the stock. Xylem traded as high as $138.68 and last traded at $138.41, with a volume of 421892 shares. The stock had previously closed at $137.21.

A number of other research firms have also recently weighed in on XYL. BNP Paribas began coverage on Xylem in a report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price target for the company. Citigroup increased their price target on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Mizuho increased their price target on Xylem from $110.00 to $135.00 and gave the stock a “neutral” rating in a report on Friday. Robert W. Baird increased their price target on Xylem from $151.00 to $155.00 and gave the stock an “outperform” rating in a report on Friday. Finally, Oppenheimer increased their target price on Xylem from $142.00 to $147.00 and gave the stock an “outperform” rating in a research note on Friday. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $140.70.

Insider Buying and Selling at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares in the company, valued at approximately $1,431,032.50. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in Xylem by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock worth $3,207,683,000 after buying an additional 187,847 shares during the last quarter. Morgan Stanley grew its stake in Xylem by 11.5% during the 3rd quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company’s stock worth $412,267,000 after buying an additional 466,911 shares during the last quarter. Invesco Ltd. grew its stake in Xylem by 35.1% during the 3rd quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company’s stock worth $380,762,000 after buying an additional 1,086,102 shares during the last quarter. Royal Bank of Canada grew its stake in Xylem by 10.6% during the 3rd quarter. Royal Bank of Canada now owns 3,408,200 shares of the industrial products company’s stock worth $310,249,000 after buying an additional 327,383 shares during the last quarter. Finally, Baillie Gifford & Co. grew its stake in Xylem by 2.3% during the 4th quarter. Baillie Gifford & Co. now owns 3,066,639 shares of the industrial products company’s stock worth $350,701,000 after buying an additional 69,619 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Up 1.5 %

The business has a 50 day moving average of $128.91 and a 200-day moving average of $115.87. The stock has a market cap of $33.75 billion, a PE ratio of 49.54, a P/E/G ratio of 2.67 and a beta of 1.08. The company has a current ratio of 1.67, a quick ratio of 1.22 and a debt-to-equity ratio of 0.19.

Xylem (NYSE:XYL) last announced its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.84 by $0.06. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The company had revenue of $2.03 billion for the quarter, compared to the consensus estimate of $2 billion. During the same period last year, the business posted $0.72 EPS. The company’s revenue was up 40.4% on a year-over-year basis. Equities research analysts predict that Xylem Inc. will post 4.24 EPS for the current fiscal year.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.